Lynn M. Schuchter is a medical oncologist specializing in melanoma and a leading figure in skin cancer research and care. She directs the Tara Miller Melanoma Center at Penn Medicine, serves as Chief of the Division of Hematology/Oncology at the Perelman School of Medicine at the University of Pennsylvania, and holds the C. Willard Robinson Professorship in Hematology/Oncology. Schuchter is the immediate past president of the American Society of Clinical Oncology (2023–2024); her presidential theme, “The Art and Science of Cancer Care: From Comfort to Cure,” emphasized integrating scientific innovation with compassionate, patient-centered care.
An internationally recognized leader in melanoma, Schuchter’s research focuses on immunotherapy, targeted therapies and mechanisms of treatment resistance. Her major contributions to clinical trials have helped transform outcomes for patients with advanced melanoma. She is a dedicated mentor and advocate for women in oncology and received the ASCO Women Who Conquer Cancer Mentorship Award for her sustained commitment to developing future leaders.
Schuchter is named among The 100 Most Influential People in Oncology in 2025, a list that recognizes changemakers who have shaped current oncology practice and continue to drive innovation in research, advocacy, philanthropy, leadership and education. The list’s publishers say they will continue to acknowledge and elevate other deserving voices in daily publications from across the world.
Leave a Reply